KR101162991B1 - 트리터펜 함유 올레오겔 형성제, 트리터펜 함유 올레오겔 및 트리터펜 함유 올리오겔을 생성하기 위한 방법 - Google Patents

트리터펜 함유 올레오겔 형성제, 트리터펜 함유 올레오겔 및 트리터펜 함유 올리오겔을 생성하기 위한 방법 Download PDF

Info

Publication number
KR101162991B1
KR101162991B1 KR1020077001575A KR20077001575A KR101162991B1 KR 101162991 B1 KR101162991 B1 KR 101162991B1 KR 1020077001575 A KR1020077001575 A KR 1020077001575A KR 20077001575 A KR20077001575 A KR 20077001575A KR 101162991 B1 KR101162991 B1 KR 101162991B1
Authority
KR
South Korea
Prior art keywords
oleogel
triterpene
oil
weight
triterpenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077001575A
Other languages
English (en)
Korean (ko)
Other versions
KR20070046821A (ko
Inventor
아르민 쉬플러
Original Assignee
비르켄 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101162991(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 비르켄 아게 filed Critical 비르켄 아게
Publication of KR20070046821A publication Critical patent/KR20070046821A/ko
Application granted granted Critical
Publication of KR101162991B1 publication Critical patent/KR101162991B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Measuring Volume Flow (AREA)
KR1020077001575A 2004-06-22 2005-06-21 트리터펜 함유 올레오겔 형성제, 트리터펜 함유 올레오겔 및 트리터펜 함유 올리오겔을 생성하기 위한 방법 Expired - Lifetime KR101162991B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004030044.5 2004-06-22
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
PCT/EP2005/006710 WO2005123037A1 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels

Publications (2)

Publication Number Publication Date
KR20070046821A KR20070046821A (ko) 2007-05-03
KR101162991B1 true KR101162991B1 (ko) 2012-07-10

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077001575A Expired - Lifetime KR101162991B1 (ko) 2004-06-22 2005-06-21 트리터펜 함유 올레오겔 형성제, 트리터펜 함유 올레오겔 및 트리터펜 함유 올리오겔을 생성하기 위한 방법

Country Status (31)

Country Link
US (2) US8536380B2 (https=)
EP (1) EP1758555B2 (https=)
JP (1) JP4468987B2 (https=)
KR (1) KR101162991B1 (https=)
CN (1) CN1972668B (https=)
AT (1) ATE423546T1 (https=)
AU (1) AU2005253732C1 (https=)
BE (1) BE2016C035I2 (https=)
BR (1) BRPI0512288B8 (https=)
CA (1) CA2571606C (https=)
CY (2) CY1109066T1 (https=)
DE (2) DE102004030044A1 (https=)
DK (1) DK1758555T4 (https=)
ES (1) ES2323082T5 (https=)
FR (1) FR16C1003I2 (https=)
HU (1) HUS1600032I1 (https=)
IL (1) IL180057A (https=)
LT (1) LTC1758555I2 (https=)
LU (1) LU93142I2 (https=)
MX (1) MXPA06015233A (https=)
NL (1) NL300823I2 (https=)
NO (2) NO336747B1 (https=)
NZ (1) NZ552280A (https=)
PL (1) PL1758555T5 (https=)
PT (1) PT1758555E (https=)
RS (1) RS50832B2 (https=)
RU (1) RU2430717C2 (https=)
SI (1) SI1758555T2 (https=)
UA (1) UA88308C2 (https=)
WO (1) WO2005123037A1 (https=)
ZA (1) ZA200610304B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (de) * 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
PL2335675T3 (pl) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Wolne od emulgatorów, stabilizowane polimerem formulacje pianki
EP2363108B1 (de) 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Schaumformulierungen enthaltend mindestens ein Triterpenoid
KR101723272B1 (ko) 2011-06-21 2017-04-18 비브이더블유 홀딩 에이쥐 보스웰릭산을 포함하는 메디컬 디바이스
HRP20250066T1 (hr) * 2016-05-12 2025-03-14 Rudjer Boskovic Institute Organski gelatori biljnog ulja niske molekularne težine
WO2018017576A1 (en) * 2016-07-18 2018-01-25 Rolf Daniels Betulin-containing water-in-oil foams and compositions thereof
US20180258277A1 (en) * 2017-03-10 2018-09-13 Kraton Polymers U.S. Llc Fusible oil gel compositions and methods of making and using same
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
EP3703723A4 (en) 2017-10-31 2021-12-15 KaliVir Immunotherapeutics, Inc. ONCOLYTIC PLATFORM VECTOR FOR SYSTEMS ADMINISTRATION
CN111356479A (zh) 2018-01-04 2020-06-30 安瑞特研究有限公司 含有白桦脂醇的桦树皮提取物及其制剂
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
TW202227621A (zh) 2020-11-19 2022-07-16 美商凱立凡爾免疫治療股份有限公司 重塑腫瘤微環境的溶瘤免疫療法
BR112023022681A2 (pt) 2021-04-30 2024-01-23 Kalivir Immunotherapeutics Inc Vírus oncolíticos para expressão modificada de mhc
DE102024116319B3 (de) 2024-06-11 2025-10-30 Fuchs SE Schmierfett-Zusammensetzungen enthaltend pentacyclische Triterpene als Co-Verdicker, deren Verwendung und Verfahren zu deren Herstellung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) * 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) * 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
ATE239490T1 (de) 1999-07-09 2003-05-15 Bsp Pharma As Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
ATE262283T1 (de) * 2000-02-10 2004-04-15 Loders Croklaan Bv Fettmischungen mit kristallmodifikatoren
EA013736B1 (ru) * 2000-03-28 2010-06-30 Биркен Гмбх Эмульсия, содержащая растительный экстракт, в частности экстракт берёзовой коры, и ее применение
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
US6689767B2 (en) * 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
AU2001294953A1 (en) * 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) * 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
LTC1758555I2 (lt) 2017-11-10
NZ552280A (en) 2010-10-29
CY2016025I2 (el) 2016-10-05
NO336747B1 (no) 2015-10-26
CY2016025I1 (el) 2016-10-05
EP1758555B2 (de) 2011-09-07
DK1758555T4 (da) 2011-12-19
SI1758555T1 (sl) 2009-08-31
AU2005253732B2 (en) 2009-07-16
CN1972668A (zh) 2007-05-30
EP1758555A1 (de) 2007-03-07
ATE423546T1 (de) 2009-03-15
RS50832B2 (sr) 2018-09-28
DE102004030044A1 (de) 2006-01-12
FR16C1003I1 (https=) 2016-08-26
NO2016012I2 (no) 2016-07-07
LU93142I9 (https=) 2024-11-04
US20140050790A1 (en) 2014-02-20
DK1758555T3 (da) 2009-06-22
RU2430717C2 (ru) 2011-10-10
SI1758555T2 (sl) 2009-08-31
CN1972668B (zh) 2013-01-09
DE502005006701D1 (de) 2009-04-09
FR16C1003I2 (fr) 2018-01-19
HUS1600032I1 (hu) 2016-08-29
ES2323082T5 (es) 2012-01-05
US8536380B2 (en) 2013-09-17
AU2005253732A1 (en) 2005-12-29
IL180057A (en) 2013-11-28
RS50832B (sr) 2010-08-31
BRPI0512288B8 (pt) 2021-05-25
CA2571606C (en) 2011-07-19
JP2008503530A (ja) 2008-02-07
CY1109066T1 (el) 2014-07-02
EP1758555B1 (de) 2009-02-25
ES2323082T3 (es) 2009-07-06
BRPI0512288A (pt) 2008-03-25
NL300823I2 (nl) 2017-06-22
WO2005123037A1 (de) 2005-12-29
UA88308C2 (ru) 2009-10-12
US20070299285A1 (en) 2007-12-27
US8828444B2 (en) 2014-09-09
AU2005253732C1 (en) 2010-01-21
KR20070046821A (ko) 2007-05-03
JP4468987B2 (ja) 2010-05-26
NO2016012I1 (no) 2016-07-07
PL1758555T5 (pl) 2011-12-30
ZA200610304B (en) 2007-11-28
PL1758555T3 (pl) 2009-07-31
PT1758555E (pt) 2009-04-24
NO20070390L (no) 2007-03-16
MXPA06015233A (es) 2007-12-12
RU2007102084A (ru) 2008-07-27
BE2016C035I2 (https=) 2024-10-08
CA2571606A1 (en) 2005-12-29
IL180057A0 (en) 2007-05-15
BRPI0512288B1 (pt) 2019-05-21
LU93142I2 (fr) 2016-09-06

Similar Documents

Publication Publication Date Title
US8828444B2 (en) Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel
JP6263239B2 (ja) 表皮水泡症の創傷治癒剤
JPH0249719A (ja) 易水分散・可溶性能を有する油溶性ビタミン粉末
EP0006724A1 (en) Pharmaceutical compositions containing urea
KR20130056864A (ko) 국소적 피부 적용에 적합한 분무-펌핑가능한 조성물
JPS63221835A (ja) 安定な水中油型エマルジヨンの製造方法
ITMI972277A1 (it) Composizioni cosmetiche a base di acido azelaico
JPS58225010A (ja) コルチコステロイド類外用製剤
CN112423763A (zh) 糠酸氟替卡松鼻制剂组合物
Mangunsong et al. Nanoparticle Betacarotene Formulated in Cetyl Alcohol, Glycerine, Stearic Acid and TEA as Based Cream
WO2000041702A1 (fr) Preparation steroide externe
WO1996007414A1 (en) Ointment

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20150608

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160510

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20170519

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20180424

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20190418

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

PC1801 Expiration of term

St.27 status event code: N-4-6-H10-H14-oth-PC1801

Not in force date: 20250622

Ip right cessation event data comment text: Termination Category : EXPIRATION_OF_DURATION

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)